查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026758

雙能量X光吸收（DXA）市場檢測法至2034年－按類型、技術、應用、最終用戶和地區分類的全球分析

Dual-energy X-ray Absorptiometry Market Forecasts to 2034 - Global Analysis By Type, Technology, Application, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球雙能量 X光檢測法(DEXA) 市場預計到 2026 年將達到 8.246 億美元，在預測期內以 10.0% 的複合年成長率成長，到 2034 年將達到 17.676 億美元。

雙能量X光檢測法（DEXA）能夠準確、非侵入性地測量骨骼密度（BMD）和身體組成。 DEXA利用兩束能量不同的低劑量X光，區分骨骼、脂肪和瘦組織，從而提供個體骨骼健康和整體身體組成的準確資訊。 DEXA掃描常用於評估骨質疏鬆症，並有助於確定骨折風險和骨骼密度下降。

根據國際骨質疏鬆症基金會的數據，50歲以上的女性中約有三分之一患有骨質疏鬆症，男性中約有五分之一患有骨質疏鬆症。該基金會也估計，美國、歐洲和日本共有超過7,500萬人與骨質疏鬆症有關。

人口老化的過程

隨著全球老年人口的成長，與老齡化相關的骨質流失，即骨質疏鬆症，日益普遍。雙能量X光吸收法（DEXA）在診斷這種骨質疏鬆症方面至關重要，因為它是一種關鍵的診斷工具，能夠實現快速干涉，預防骨折及其相關併發症。此外，定期進行DEXA檢查對於老齡化社會的持續健康管理必不可少，從而促進老年保健的早期干預。

設備和維護成本

醫療機構可能因雙能量X光吸收儀（DEXA）設備的初始投資成本以及持續的維護費用而面臨財務困境。這些成本受其複雜技術和為確保測量精度所需的持續校準的影響。此外，這些財務因素凸顯了在醫療保健規劃中考慮財務因素的必要性，並可能阻礙DEXA的廣泛應用，尤其是在資源有限的環境中。

在研發和藥物開發領域中得到更廣泛的應用。

除了臨床診斷外，雙能量X光吸收法（DEXA）還可用於研究，是評估藥物對骨骼健康影響的寶貴工具。此外，它能夠追蹤骨骼成分和密度的變化，為藥物研發提供關鍵訊息，從而實現對骨質疏鬆症等疾病更有效、更有針對性的治療。製藥公司與學術機構之間的合作，為該領域的進一步研究提供了機會。

替代技術與競爭環境

新興的替代技術和不斷變化的競爭格局對雙能量X光吸收法（DEXA）市場構成威脅。定量CT（QCT）和周邊定量CT（pQCT）等競爭性診斷方法正在削弱DEXA的市場主導地位。此外，替代技術的持續發展可能會分散資金和注意力，使傳統DEXA系統失去市場，從而影響市場佔有率和普及率。

新冠疫情的影響：

雙能量X光檢測法（DEXA）市場受到新冠肺炎疫情的顯著影響。醫療服務中斷、資源重新分配以應對疫情相關挑戰以及安全疑慮的加劇，導致DEXA掃描等常規診斷程序減少。此外，患者就診次數減少、非緊急會診延遲以及醫療預算限制等因素也暫時阻礙了DEXA技術的應用。然而，疫情凸顯了預防醫學的重要性，隨著醫療系統在疫情後恢復階段優先進行常規篩檢和診斷程序，DEXA技術或許有望迎來復甦。

在預測期內，軸向雙能量X骨質密度檢測設備預計將佔據最大的市場佔有率。

軸向雙能量X光吸收法（DEXA）骨質密度檢測設備預計將佔據雙能量X光檢測法（DEXA）市場最大的佔有率。這些設備主要用於測量髖部和脊椎的骨骼密度，這兩個部位對於評估骨折和骨質疏鬆風險至關重要。軸向DEXA掃描可為醫生提供高度精確且全面的骨骼健康訊息，有助於診斷骨質疏鬆等疾病並評估治療效果。此外，不同醫療機構的臨床醫生更傾向於使用軸向配置，因為這種配置能夠對中心骨骼區域進行全面檢查。隨著骨質疏鬆症盛行率的上升和骨骼健康日益受到重視，軸向DEXA骨質密度檢測設備在疾病管理和預防醫學中將繼續發揮不可或缺的作用。

在預測期內，人體組成分析細分市場預計將呈現最高的複合年成長率。

在人體組成分析領域，雙能量X光檢測法（DEXA）市場預計將以最高的複合年成長率成長。先進診斷工具市場的成長主要得益於人們對人體組成對整體健康、健身和疾病預防影響的認知不斷提高。除了傳統的骨骼密度測試外，人體組成分析還能提供關於瘦肌肉量、脂肪分佈和其他關鍵因素的詳細分析。此外，這項技術對於解決全球範圍內肥胖、代謝紊亂和導致肌肉萎縮的疾病等問題至關重要。

市佔率最大的地區：

北美地區佔據最大的市場佔有率，並持續在雙能量X光檢測法（DEXA）市場保持主導地位。特別是美國，擁有成熟且技術先進的醫療產業。該地區在醫學研究、尖端設備和完善的基礎設施方面投入大量資金。此外，高額的醫療費用支出、健全的法規環境以及對創新的持續關注，也凸顯了該地區的領先地位。正因如此，以美國為中心的北美地區持續對全球醫療保健產業的發展產生著舉足輕重的影響。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。醫療基礎設施投資的增加、人口老化帶來的不斷變化的醫療需求以及日益增強的健康意識，都是推動這一顯著成長的因素。中國、印度和日本在製藥、醫療技術和醫療服務領域的進步方面處於主導地位。此外，對數位醫療解決方案的重視和政府的支持，正在鞏固亞太地區作為不斷發展的醫療保健領域關鍵樞紐的地位，並顯著促進市場複合年成長率的成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球雙能量X光檢測法（DXA）市場：按類型分類

  • 獨立版
  • 可攜式的
  • 其他類型

第6章 全球雙能量X光檢測法（DXA）市場：依技術分類

  • 軸向雙能量X骨質密度檢測設備
  • 周邊雙能量X骨質密度檢測設備
  • 其他技術

第7章 全球雙能量X光檢測法（DXA）市場：依應用分類

  • 骨質疏鬆症
  • 身體組成分析
  • 骨折管理
  • 骨骼密度測量
  • 其他用途

第8章 全球雙能量X光檢測法（DXA）市場：依最終用戶分類

  • 醫院和診所
  • 診斷中心
  • 專業設施
  • 其他最終用戶

第9章 全球雙能量X光檢測法（DXA）市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第10章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • Osteometer Meditech Inc
  • Medilink International
  • GE Healthcare
  • Shenzhen XRAY Electric Co., Ltd.
  • BeamMed Ltd
  • Furuno Electric Co., Ltd.
  • Hologic, Inc.
  • Scanflex Healthcare AB
  • Medonica Co., Ltd
  • Fonar Corporation
  • Swissray Medical AG
Product Code: SMRC24749

According to Stratistics MRC, the Global Dual-energy X-ray Absorptiometry (DEXA) Market is accounted for $824.6 million in 2026 and is expected to reach $1767.6 million by 2034 growing at a CAGR of 10.0% during the forecast period. Bone mineral density (BMD) and body composition can be measured with accuracy and without invasiveness using dual-energy X-ray absorptiometry (DEXA). DEXA provides precise information about an individual's skeletal health and overall body composition by using low-dose X-ray beams at two different energy levels to differentiate between bone, fat, and lean tissue. DEXA scans are frequently used to evaluate osteoporosis and are useful in determining fracture risk and bone mineral loss.

According to the International Osteoporosis Foundation, around one in three women and one in five men over the age of 50 are suffering from osteoporosis. The organization also estimated that over 75 million patients are associated with osteoporosis in the U.S., Europe, and Japan.

Market Dynamics:

Driver:

Increasingly elderly population

Age-related bone loss, or osteoporosis, is becoming more common as the world's senior population grows. DEXA is essential for diagnosing this vulnerability because it is a critical diagnostic tool that enables prompt interventions to avoid fractures and associated complications. Additionally, regular DEXA scans are required for the ongoing health management of the aging population, which encourages an early approach to senior healthcare.

Restraint:

Equipment and maintenance costs

Healthcare facilities may face financial difficulties with the initial capital expenditure for DEXA equipment as well as continuing maintenance costs. The cost of all this is influenced by the complex technology and constant calibration needed to ensure accuracy. Furthermore, this financial factor highlights the need for financial considerations in healthcare planning and may prevent DEXA from being widely adopted, particularly in settings where resources are scarce.

Opportunity:

Increasing research and drug development applications

Beyond clinical diagnostics, DEXA can be used in research applications and is a useful tool for evaluating how medications affect bone health. Moreover, its function in tracking alterations in the composition and density of bone offers vital information for medication development, enabling more effective and focused treatments for diseases like osteoporosis. Opportunities for more research in this area are provided by partnerships between pharmaceutical companies and academic institutions.

Threat:

Alternative technologies and the competitive environment

Emerging alternative technologies and changing competitive landscapes pose threats to the DEXA market. The dominance of DEXA in the market is threatened by competing diagnostic modalities like quantitative computed tomography (QCT) and peripheral quantitative computed tomography (pQCT). Additionally, market share and adoption rates may be impacted if ongoing developments in alternative technologies draw capital and attention away from conventional DEXA systems.

Covid-19 Impact:

The market for dual-energy X-ray absorptiometry (DEXA) has been greatly impacted by the COVID-19 pandemic. Routine diagnostic procedures, such as DEXA scans, have decreased as a result of disruptions to healthcare services, the reallocation of resources to address pandemic-related challenges, and increased safety concerns. Furthermore, the adoption of DEXA technology has temporarily stalled due to a combination of factors, including fewer patient visits to healthcare facilities, delays in non-urgent medical appointments, and financial constraints on healthcare budgets. But the pandemic has also highlighted the value of preventive healthcare, which may present prospects for DEXA's comeback as long as healthcare systems give regular screenings and diagnostic procedures top priority during the post-pandemic recovery period.

The Axial DEXA Bone Densitometer segment is expected to be the largest during the forecast period

It is projected that axial DEXA bone densitometers will command the largest market share in dual-energy X-ray absorptiometry (DEXA). These instruments are mainly used to assess the bone mineral density in the hip and spine, which are important regions to assess the risk of fractures and osteoporosis. Axial DEXA scans help physicians diagnose diseases like osteoporosis and evaluate the efficacy of treatments by giving them extremely precise and comprehensive information about bone health. Moreover, clinicians in a variety of healthcare settings prefer the axial configuration because it enables a thorough examination of central skeletal sites. As osteoporosis becomes more common and bone health becomes more important, axial DEXA bone densitometers will always be essential for managing diseases and providing preventive care.

The Body Composition Analysis segment is expected to have the highest CAGR during the forecast period

The market for dual-energy X-ray absorptiometry (DEXA) is expected to grow at the highest CAGR in the body composition analysis segment. The market for advanced diagnostic tools has been driven by growing awareness of the influence of body composition on overall health, fitness, and disease prevention. Beyond conventional bone density tests, body composition analysis offers a thorough analysis of lean muscle mass, fat distribution, and other important factors. Additionally, in order to address the global concerns surrounding obesity, metabolic disorders, and conditions that cause muscle wasting, technology is essential.

Region with largest share:

With the largest share, North America has continued to hold a dominant position in the dual-energy X-ray absorptiometry (DEXA) market. Particularly in the United States, the healthcare industry is well-established and technologically sophisticated, with large expenditures made in medical research, state-of-the-art equipment, and a vast infrastructure. Furthermore, the prominence of the region is emphasized by the high level of healthcare spending, the strong regulatory environment, and the ongoing emphasis on innovation. Because of this, North America-led by the United States-continues to have a significant influence on how the global healthcare sector develops.

Region with highest CAGR:

The Asia-Pacific region is expected to have the highest CAGR over the projected period. Growing investments in healthcare infrastructure, an aging population with evolving healthcare needs, and growing healthcare awareness are all factors contributing to this notable growth. Leading nations in the advancement of pharmaceuticals, medical technology, and healthcare services are China, India, and Japan. Additionally, the region's emphasis on digital health solutions, along with encouraging government initiatives, positions Asia-Pacific as a major hub for the changing healthcare landscape and contributes significantly to the market's rising compound annual growth rate.

Key players in the market

Some of the key players in Dual-energy X-ray Absorptiometry (DEXA) market include Osteometer Meditech Inc, Medilink International, GE Healthcare, Shenzhen XRAY Electric Co., Ltd., BeamMed Ltd, Furuno Electric Co., Ltd., Hologic, Inc., Scanflex Healthcare AB, Medonica Co., Ltd, Fonar Corporation and Swissray Medical AG.

Key Developments:

In December 2023, GE Healthcare has entered into a distribution agreement with mobile-first clinical surveillance technology provider, AirStrip to expand AirStrip Cardiology and Patient Monitoring solutions in the US. The mobile application from AirStrip enables clinicians to view clinical data on the web and on mobile devices. It connects with cardiac rhythm strips and 12-lead ECGs, allowing clinicians to monitor numerous patients at the same time and can receive STEMI notifications.

In October 2023, MediLink Therapeutics, announced today that it has entered into a strategic research collaboration and worldwide license agreement with BioNTech SE, a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases, on the development of a next-generation antibody-drug conjugate candidate ("ADC"), against Human Epidermal Growth Factor Receptor 3 (HER3).

In September 2023, Hologic Inc. and Bayer today announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the detection of breast cancer for women in multiple countries across the European, Canadian and Asia Pacific regions. CEM is a highly sensitive and relatively low-cost breast imaging modality that combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide treatment decisions.

Types Covered:

  • Standalone
  • Portable
  • Other Types

Technologies Covered:

  • Axial DEXA Bone Densitometer
  • Peripheral DEXA Bone Densitometer
  • Other Technologies

Applications Covered:

  • Osteoporosis
  • Body Composition Analysis
  • Fracture Management
  • Bone Densitometry
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Centers
  • Specialty Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Dual-energy X-ray Absorptiometry (DEXA) Market, By Type

  • 5.1 Introduction
  • 5.2 Standalone
  • 5.3 Portable
  • 5.4 Other Types

6 Global Dual-energy X-ray Absorptiometry (DEXA) Market, By Technology

  • 6.1 Introduction
  • 6.2 Axial DEXA Bone Densitometer
  • 6.3 Peripheral DEXA Bone Densitometer
  • 6.4 Other Technologies

7 Global Dual-energy X-ray Absorptiometry (DEXA) Market, By Application

  • 7.1 Introduction
  • 7.2 Osteoporosis
  • 7.3 Body Composition Analysis
  • 7.4 Fracture Management
  • 7.5 Bone Densitometry
  • 7.6 Other Applications

8 Global Dual-energy X-ray Absorptiometry (DEXA) Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals & Clinics
  • 8.3 Diagnostic Centers
  • 8.4 Specialty Centers
  • 8.5 Other End Users

9 Global Dual-energy X-ray Absorptiometry (DEXA) Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Osteometer Meditech Inc
  • 11.2 Medilink International
  • 11.3 GE Healthcare
  • 11.4 Shenzhen XRAY Electric Co., Ltd.
  • 11.5 BeamMed Ltd
  • 11.6 Furuno Electric Co., Ltd.
  • 11.7 Hologic, Inc.
  • 11.8 Scanflex Healthcare AB
  • 11.9 Medonica Co., Ltd
  • 11.10 Fonar Corporation
  • 11.11 Swissray Medical AG

List of Tables

  • Table 1 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2023-2034) ($MN)
  • Table 4 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2023-2034) ($MN)
  • Table 5 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 6 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2023-2034) ($MN)
  • Table 7 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 8 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 9 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 10 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2023-2034) ($MN)
  • Table 11 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2023-2034) ($MN)
  • Table 12 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2023-2034) ($MN)
  • Table 13 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2023-2034) ($MN)
  • Table 14 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2023-2034) ($MN)
  • Table 15 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 16 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2023-2034) ($MN)
  • Table 17 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 18 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 19 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 20 Global Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 21 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Country (2023-2034) ($MN)
  • Table 22 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2023-2034) ($MN)
  • Table 23 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2023-2034) ($MN)
  • Table 24 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2023-2034) ($MN)
  • Table 25 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 26 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2023-2034) ($MN)
  • Table 27 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 28 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 29 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 30 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2023-2034) ($MN)
  • Table 31 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2023-2034) ($MN)
  • Table 32 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2023-2034) ($MN)
  • Table 33 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2023-2034) ($MN)
  • Table 34 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2023-2034) ($MN)
  • Table 35 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 36 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2023-2034) ($MN)
  • Table 37 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 38 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 39 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 40 North America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 41 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Country (2023-2034) ($MN)
  • Table 42 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2023-2034) ($MN)
  • Table 43 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2023-2034) ($MN)
  • Table 44 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2023-2034) ($MN)
  • Table 45 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 46 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2023-2034) ($MN)
  • Table 47 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 48 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 49 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 50 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2023-2034) ($MN)
  • Table 51 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2023-2034) ($MN)
  • Table 52 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2023-2034) ($MN)
  • Table 53 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2023-2034) ($MN)
  • Table 54 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2023-2034) ($MN)
  • Table 55 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 56 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2023-2034) ($MN)
  • Table 57 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 58 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 59 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 60 Europe Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 61 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Country (2023-2034) ($MN)
  • Table 62 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2023-2034) ($MN)
  • Table 63 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2023-2034) ($MN)
  • Table 64 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2023-2034) ($MN)
  • Table 65 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 66 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2023-2034) ($MN)
  • Table 67 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 68 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 69 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 70 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2023-2034) ($MN)
  • Table 71 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2023-2034) ($MN)
  • Table 72 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2023-2034) ($MN)
  • Table 73 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2023-2034) ($MN)
  • Table 74 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2023-2034) ($MN)
  • Table 75 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 76 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2023-2034) ($MN)
  • Table 77 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 78 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 79 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 80 Asia Pacific Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 81 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Country (2023-2034) ($MN)
  • Table 82 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2023-2034) ($MN)
  • Table 83 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2023-2034) ($MN)
  • Table 84 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2023-2034) ($MN)
  • Table 85 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 86 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2023-2034) ($MN)
  • Table 87 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 88 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 89 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 90 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2023-2034) ($MN)
  • Table 91 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2023-2034) ($MN)
  • Table 92 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2023-2034) ($MN)
  • Table 93 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2023-2034) ($MN)
  • Table 94 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2023-2034) ($MN)
  • Table 95 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 96 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2023-2034) ($MN)
  • Table 97 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 98 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 99 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 100 South America Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 101 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Country (2023-2034) ($MN)
  • Table 102 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Type (2023-2034) ($MN)
  • Table 103 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Standalone (2023-2034) ($MN)
  • Table 104 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Portable (2023-2034) ($MN)
  • Table 105 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 106 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Technology (2023-2034) ($MN)
  • Table 107 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Axial DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 108 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Peripheral DEXA Bone Densitometer (2023-2034) ($MN)
  • Table 109 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 110 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Application (2023-2034) ($MN)
  • Table 111 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Osteoporosis (2023-2034) ($MN)
  • Table 112 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Body Composition Analysis (2023-2034) ($MN)
  • Table 113 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Fracture Management (2023-2034) ($MN)
  • Table 114 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Bone Densitometry (2023-2034) ($MN)
  • Table 115 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 116 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By End User (2023-2034) ($MN)
  • Table 117 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 118 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 119 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 120 Middle East & Africa Dual-energy X-ray Absorptiometry (DEXA) Market Outlook, By Other End Users (2023-2034) ($MN)